Our Company Overview Investor Relations CareersPharma ServicesNeoGenomics offers lab services for oncology clinical trialsLearn moreCOVID-19Precision Medicine during this CrisisClick here to viewDONATE YOUR PLASMALatest Presented: August 19, 2020 Source: Webinar The Role of Liquid Biopsy Testing in Lung Cancer An overview of testing options for patients with NSCLC Learn More Published: July 28, 2020 Source: Press Release NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic Learn More Published: July 20, 2020 Source: Press Release NeoGenomics Announces Board Appointments Learn More Image Published: July 14, 2020 Source: Article Liquid Biopsy Testing for PIK3CA Mutation For years, researchers have looked into liquid biopsy as a potentially useful tool to help Health… Learn More Published: July 1, 2020 Source: Press Release NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020 Learn More New Tests Image Available: August 4, 2020 Methodology: FISH, Molecular NeoTYPE® Follicular Lymphoma Profile The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation… Learn More Image Available: August 4, 2020 Methodology: FISH, Molecular NeoTYPE® Follicular Lymphoma Profile The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation… Learn More Image Available: July 13, 2020 Methodology: FISH PDGFB Rearrangement (22q13) Probe(s): PDGFB (22q13.1) Disease(s): Dermatofibrosarcoma protuberans (DFSP) Learn More Image Available: July 13, 2020 Methodology: FISH MYC Amplification for Angiosarcoma Probes: MYC (8q24) | Centromere 8 Disease(s): Angiosarcoma Learn More Image Available: June 29, 2020 Methodology: Molecular NeoLAB® Solid Tumor Liquid Biopsy The NeoLAB Solid Tumor Liquid Biopsy is a next-gen sequencing assay designed to detect mutations in… Learn More
